Page 6 - Roche Hemlibra Non-inhibitors - Product Monograph
P. 6
Repeated intra articular bleeds into the same joints:
Swelling
Significant Limited
joint pain range of motion
Hemophilic arthropathy may ultimately require surgical intervention, including joint replacement at
young age (Riley et al. 2011). Increased functional disability due to hemophilia symptoms is a major
burden for patients, affecting daily life activities (Tlacuilo Parra et al. 2010; Witkop et al. 2015). Costs
of care are especially high with joint bleeds and hemophilic arthropathy.
HEALTH-RELATED QOL
The symptom and treatment burden associated with hemophilia A can have a major impact
on HRQoL of hemophilic patients through the following:
• Pain has been shown to have a considerable impact on patient's HRQoL and interferes with
patient’s activities (Forsyth et al. 2015).
• Worse physical HRQoL has been reported for patients with hemophilia A compared with the
general population (Poon et al. 2012; Pollmann et al. 2013; St Louis et al. 2016), with physical
HRQoL decreasing significantly with increasing severity of the disease (Poon et al. 2012; Pollmann
et al. 2013).
• Repeated intra articular bleeding in the same joints (target joints) is a major contributor to
decreased HRQoL in patients with hemophilia A, because the joint damage associated with
multiple hemarthroses may progress to hemophilic arthropathy (Klamroth et al. 2011; Riley et al.
2011; Gringeri et al. 2013).
While physical limitations are a key cause of diminished HRQoL, the psychological impact,
coping strategies, and emotional reactions to a life restricting disease vary with life stage and by
person, and are important consequences beyond the physical problems the condition can
cause (Cassis 2007).
3.2. CAREGIVER BURDEN
Having a family member with hemophilia inevitably increases the burden on the caregivers and
the family (Khair and von Mackenson 2017).
Hemophilia has intangible costs, including reduced QoL, pain and suffering of the individual
and family, and emotional and physical toll on the patient and caregivers.
HEMLIBRA Monograph-Non-inhibitors | 04
®